P26663 (POLG_HCVBK) Hepatitis C virus genotype 1b (isolate BK) (HCV)

Genome polyprotein UniProtKBAFDB90v4InterProInteractive Modelling

3010 aa; Sequence (Fasta)

Available Structures

Envelope glycoprotein E2 384-746; PRO_0000037533

DescriptionPDB IDOligo-stateRangeLigands
Structure of the Hepatitis C virus envelope glycoprotein E2 antigenic region 412-423 bound to the b… Heteromer
412-423
GOL;CL;
Assess
Structure of the Hepatitis C virus envelope glycoprotein E2 antigenic region 412-423 bound to the b… Heteromer
412-423
NA;K;
Assess
Structure of the HCV1-C1 Antibody-Antigen Complex Heteromer
412-423
ACT;CA;
Assess
TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
8fsj.1.Amonomer0.66421-704
87.57
Assess

Protease NS2 810-1026; PRO_0000037535

DescriptionPDB IDOligo-stateRangeLigands
Discovery of an allosteric mechanism for the regulation of HCV NS3 protein functionhomo-2-mer1013-1687
PW1;
Assess
Discovery of an allosteric mechanism for the regulation of HCV NS3 protein functionhomo-2-mer1013-1687
1LH;
Assess
Discovery of an allosteric mechanism for the regulation of HCV NS3 protein functionhomo-2-mer1013-1687
DJL;
Assess
Discovery of an allosteric mechanism for the regulation of HCV NS3 protein functionhomo-2-mer1013-1687
4VA;
Assess
Discovery of an allosteric mechanism for the regulation of HCV NS3 protein functionhomo-2-mer1013-1687
4VA;
Assess
Full-length HCV NS3-4A protease-helicase in complex with a macrocyclic protease inhibitor.homo-2-mer1013-1687
ZN;F9K;
Assess

Serine protease/helicase NS3 1027-1657; PRO_0000037536

DescriptionPDB IDOligo-stateRangeLigands
BK STRAIN HEPATITIS C VIRUS (HCV) NS3-NS4A Heteromer
1029-1689
ZN;
Assess
STRUCTURE OF HCV PROTEASE (BK STRAIN) Heteromer
1029-1689
ZN;
Assess
Discovery of an allosteric mechanism for the regulation of HCV NS3 protein functionhomo-2-mer1013-1687
PW1;
Assess
Discovery of an allosteric mechanism for the regulation of HCV NS3 protein functionhomo-2-mer1013-1687
1LH;
Assess
Discovery of an allosteric mechanism for the regulation of HCV NS3 protein functionhomo-2-mer1013-1687
DJL;
Assess
Discovery of an allosteric mechanism for the regulation of HCV NS3 protein functionhomo-2-mer1013-1687
4VA;
Assess
Discovery of an allosteric mechanism for the regulation of HCV NS3 protein functionhomo-2-mer1013-1687
4VA;
Assess
Full-length HCV NS3-4A protease-helicase in complex with a macrocyclic protease inhibitor.homo-2-mer1013-1687
ZN;F9K;
Assess
CRYSTAL STRUCTURE OF AN ENZYME COMPLEX FROM HEPATITIS C VIRUShomo-2-mer1029-1693
ZN;PO4;
Assess
Discovery of an allosteric mechanism for the regulation of HCV NS3 protein functionhomo-2-mer1029-1690
SO4;10L;
Assess
Discovery of an allosteric mechanism for the regulation of HCV NS3 protein functionhomo-2-mer1029-1690
SO4;20L;
Assess
Structure of hepatitis C virus (HCV) full-length NS3 complex with small-molecule ligand 5-bromo-1-m…homo-2-mer1029-1657
R2N;
Assess
Structure of hepatitis C virus (HCV) full-length NS3 complex with small-molecule ligand 3-aminobenz…homo-2-mer1029-1657
UP8;
Assess
Structure of hepatitis C virus (HCV) full-length NS3 complex with small-molecule ligand 2-(1-methyl…homo-2-mer1029-1657
3VY;
Assess
The structure of HCV NS3 helicase (Heli-80) bound with inhibitor ITMN-3479homo-2-mer1212-1656
I79;MG;CL;
Assess
CRYSTAL STRUCTURE OF RNA HELICASE FROM GENOTYPE 1B HEPATITIS C VIRUS: MECHANISM OF UNWINDING DUPLEX…homo-2-mer1216-1650
Assess
X-ray crystal structure of NS3 Helicase from HCV with a bound fragment inhibitor at 2.08 A resoluti…monomer1212-1656
NA;CL;3VY;
Assess
HEPATITIS C VIRUS NS3 PROTEINASEmonomer1028-1210
ZN;
Assess
THE SOLUTION NMR STRUCTURE OF THE N-TERMINAL PROTEASE DOMAIN OF THE HEPATITIS C VIRUS (HCV) NS3-PRO…monomer1048-1207
ZN;
Assess

Non-structural protein 4A 1658-1711; PRO_0000037537

DescriptionPDB IDOligo-stateRangeLigands
BK STRAIN HEPATITIS C VIRUS (HCV) NS3-NS4A Heteromer
1029-1689
ZN;
Assess
STRUCTURE OF HCV PROTEASE (BK STRAIN) Heteromer
1029-1689
ZN;
Assess
Crystal structure of HCV NS3/4A protease complexed with inhibitor Heteromer
Q0ZNA6;
1678-1689
ZN;1RR;SO4;
Assess
Discovery of an allosteric mechanism for the regulation of HCV NS3 protein functionhomo-2-mer1013-1687
PW1;
Assess
Discovery of an allosteric mechanism for the regulation of HCV NS3 protein functionhomo-2-mer1013-1687
1LH;
Assess
Discovery of an allosteric mechanism for the regulation of HCV NS3 protein functionhomo-2-mer1013-1687
DJL;
Assess
Discovery of an allosteric mechanism for the regulation of HCV NS3 protein functionhomo-2-mer1013-1687
4VA;
Assess
Discovery of an allosteric mechanism for the regulation of HCV NS3 protein functionhomo-2-mer1013-1687
4VA;
Assess
Full-length HCV NS3-4A protease-helicase in complex with a macrocyclic protease inhibitor.homo-2-mer1013-1687
ZN;F9K;
Assess
CRYSTAL STRUCTURE OF AN ENZYME COMPLEX FROM HEPATITIS C VIRUShomo-2-mer1029-1693
ZN;PO4;
Assess
Discovery of an allosteric mechanism for the regulation of HCV NS3 protein functionhomo-2-mer1029-1690
SO4;10L;
Assess
Discovery of an allosteric mechanism for the regulation of HCV NS3 protein functionhomo-2-mer1029-1690
SO4;20L;
Assess

Non-structural protein 5A 1973-2419; PRO_0000037539

DescriptionPDB IDOligo-stateRangeLigands
Crystal Structure of the Human Fyn SH3 domain in complex with a peptide from the Hepatitis C virus … Heteromer
P06241;
2321-2328
GOL;CL;NA;
Assess

RNA-directed RNA polymerase 2420-3010; PRO_0000037540

DescriptionPDB IDOligo-stateRangeLigands
HEPATITIS C VIRUS NS5B RNA-DEPENDENT RNA POLYMERASEhomo-2-mer2422-2985
Assess
Hepatitis C virus polymerase NS5B (BK) with amide bioisostere thumb site inhibitorhomo-2-mer2421-2981
HJZ;GOL;
Assess
Hepatitis C Virus RNA Polymerase in Complex with GTP and Manganesehomo-2-mer2420-2950
GTP;MN;
Assess
Hepatitis C Virus RNA polymerase in complex with UTP and manganesehomo-2-mer2420-2950
UTP; 10×MN;
Assess
Identification of Novel Allosteric Inhibitors of Hepatitis C Virus NS5B Polymerase Thumb Domain (Si…homo-2-mer2420-2950
QQ3;
Assess
CRYSTAL STRUCTURE OF THE RNA-DEPENDENT RNA POLYMERASE OF HEPATITIS C VIRUShomo-2-mer2420-2950
Assess
Structure of hepatitis C virus NS5B polymerase in a new crystal formmonomer2420-2985
ACY;GOL;
Assess
NS5b in complex with lactam-thiophene carboxylic acidsmonomer2422-2986
33J;
Assess
HCV NS5B GT1B N316 with GSK5852Amonomer2420-2983
1PV;
Assess
HCV NS5B GT1B N316Y with CMPD 32monomer2420-2982
690;
Assess
HCV NS5B 1b N316 bound to Compound 18monomer2420-2982
K4S;
Assess
Hepatitis C virus RNA polymerase in complex with non-nucleoside analogue inhibitormonomer2420-2982
153;
Assess
HCV NS5B GT1B N316Y with CMPD 4monomer2420-2982
1C0;
Assess
HCV NS5B GT1B N316Y with GSK5852monomer2420-2982
1PV;
Assess
3-heterocyclyl quinolone bound to HCV NS5Bmonomer2420-2982
KLI;
Assess
Crystal structure of HCV NS5B RNA polymerase complexed with a novel non-competitive inhibitor.monomer2420-2982
NH1;
Assess
Hepatitis C virus RNA polymerase in complex with non-nucleoside analogue inhibitormonomer2420-2982
154;
Assess
Crystal Structure of HCV NS5B RNA polymerase in complex with PF868554monomer2420-2981
AG0;AG6;BME;
Assess
Crystal structure of hepatitis c virus rna-dependent rna polymerase ns5b in complex with optimized …monomer2421-2982
NI;SX4;
Assess
Crystal structure of hepatitis c virus rna-dependent rna polymerase ns5b in complex with small mole…monomer2421-2982
ZN;
Assess
Crystal structure of hepatitis c virus rna-dependent rna polymerase ns5b in complex with small mole…monomer2421-2982
SX2;
Assess
Crystal structure of HCV NS5B polymerase with a novel pyridazinone inhibitormonomer2420-2981
N35;
Assess
Crystal structure of HCV NS5B polymerase in complex with a novel bicyclic dihydro-pyridinone inhibi…monomer2420-2981
YAK;
Assess
Crystal structure of hepatitis c virus rna-dependent rna polymerase ns5b in complex with optimized …monomer2421-2982
SX6;
Assess
Hepatitis C virus polymerase NS5B with saccharin inhibitor 1monomer2421-2982
H5U;
Assess
CRYSTAL STRUCTURE OF HEPATITIS C VIRUS POLYMERASE IN COMPLEX WITH INHIBITOR SB698223monomer2420-2981
698;
Assess
HCV NS5B allosteric inhibitor complexmonomer2422-2983
VRX;
Assess
Hepatitis C Virus NS5b RNA Polymerase in complex with a covalent inhibitor (5x)monomer2420-2981
SO4;5X;
Assess
Crystal structure of HCV NS5B polymerase with a novel pyridazinone inhibitormonomer2420-2981
3MS;
Assess
Crystal structure of HCV NS5B polymerase with a novel Pyridazinone inhibitormonomer2420-2981
N3H;
Assess
Hepatitis C Virus NS5b RNA Polymerase in complex with a covalent inhibitor (5ee)monomer2420-2981
SO4;5EE;
Assess
Hepatitis C Virus NS5b RNA Polymerase in complex with a covalent inhibitor (5h)monomer2420-2981
SO4;5H;
Assess
Crystal structure of HCV NS5B polymerase with a novel monocyclic dihydropyridinone inhibitormonomer2420-2981
B42;
Assess
Novel Thiazolones as HCV NS5B Polymerase Inhibitors: Further Designs, Synthesis, SAR and X-ray Comp…monomer2422-2983
VXR;
Assess
CRYSTAL STRUCTURE OF HEPATITIS C VIRUS POLYMERASE IN COMPLEX WITH INHIBITOR SB655264monomer2420-2981
699;
Assess
Thiazolone-acylsulfonamides as novel HCV NS5B polymerase allosteric inhibitors: Convergence of stru…monomer2422-2983
VR1;
Assess
Crystal structure of HCV NS5B polymerase with a novel pyridazinone inhibitormonomer2420-2981
4MS;
Assess
Crystal Structure of HCV NS5B Polymerase with a Novel Pyridazinone Inhibitormonomer2420-2981
1PD;
Assess
Crystal structure of hcv ns5b polymerase with a novel benzisothiazole inhibitormonomer2420-2981
B34;
Assess
Crystal Structure of HCV NS5B Polymerase with a Novel Pyridazinone Inhibitormonomer2420-2981
DEY;
Assess
HCV NS5B allosteric inhibitor complexmonomer2422-2983
RNA;
Assess
Crystal structure of HCV NS5B polymerase with a novel pyridazinone inhibitormonomer2420-2981
N34;
Assess
Crystal structure of hcv ns5b polymerase with a novel pyridazinone inhibitormonomer2420-2981
321;
Assess
Crystal structure of HCV NS5B polymerase with a novel monocyclic dihydro-pyridinone inhibitormonomer2420-2981
B80;
Assess
Crystal Structure of HCV NS5B Polymerase with a Novel Pyridazinone Inhibitormonomer2420-2981
2PD;
Assess
HCV NS5B RNA-dependent RNA polymerase in complex with non-nucleoside inhibitor MK-8876monomer2422-2983
9VY;
Assess
Hepatitis C virus RNA-dependent RNA polymerase NS5B with NNI-2 inhibitormonomer2421-2981
NN2;
Assess
Crystal structure of hepatitis c virus rna-dependent rna polymerase ns5b in complex with optimized …monomer2421-2981
NI;SX3;
Assess
Hepatitis C virus RNA-dependent RNA polymerase NS5B with NNI-1 inhibitormonomer2421-2981
NN3;
Assess
Hepatitis C Virus polymerase NS5B genotype 1b (BK) in complex with inhibitor 14 (N-(4-{(E)-2-[3-ter…monomer2421-2981
28V;
Assess
Crystal structure of HCV NS5b 1b with (1,1-dioxo-2H-[1,2,4]benzothiadiazin-3-yl) azolo[1,5-a]pyrimi…monomer2421-2981
B5P;GOL;
Assess
Hepatitis C Virus polymerase NS5B (BK) with fragment-based compoundsmonomer2421-2981
12R;
Assess
Hepatitis C virus polymerase NS5B with RO inhibitor for SAR studiesmonomer2421-2981
SL4;
Assess
Hepatitis C virus polymerase NS5B with saccharin inhibitormonomer2421-2981
H5S;
Assess
Hepatitis C Virus polymerase NS5B genotype 1b (BK) in complex with inhibitor 12 (N-{2-[3-tert-butyl…monomer2421-2981
28R;
Assess
Hepatitis C Virus polymerase NS5B genotype 1b (BK) in complex with inhibitor 13 (N-{2-[3-tert-butyl…monomer2421-2981
GOL;2AY;
Assess
Crystal structure of hepatitis c virus rna-dependent rna polymerase ns5b in complex with optimized …monomer2421-2981
NI;SX5;
Assess
Hepatitis C Virus polymerase NS5B genotype 1b (BK) in complex with inhibitor 4 (N-(4-{2-[3-tert-but…monomer2421-2981
DMS;28Q;
Assess
Hepatitis C virus polymerase NS5B with thiazine inhibitor 2monomer2421-2981
H59;
Assess
Hepatitis C Virus polymerase NS5B (BK) with fragment-based compoundsmonomer2421-2981
1EP;
Assess
Hepatitis C virus polymerase NS5B (BK 1-570) with HCV-796 inhibitormonomer2421-2981
79Z;
Assess
Hepatitis C virus polymerase NS5B (BK 1-570) with thiazine inhibitormonomer2421-2981
T18;NI;
Assess
Hepatitis C Virus polymerase NS5B genotype 1b (BK) in complex with Compound 48 (N-({(3S)-1-[6-tert-…monomer2421-2981
DMS;28M;
Assess
Hepatitis C Virus polymerase NS5B (BK) with fragment-based compoundsmonomer2421-2981
ZN;1ER;
Assess
Hepatitis C Virus polymerase NS5B genotype 1b (BK) in complex with RG7109 (N-{4-[6-tert-butyl-5-met…monomer2421-2981
ZN;28L;
Assess
Hepatitis C Virus polymerase NS5B genotype 1b (BK) in complex with inhibitor 2 (3-(3-tert-butyl-4-m…monomer2421-2981
MG;DMS;28O;
Assess
HCV NS5B polymerase inhibitors: Tri-substituted acylhydrazines as tertiary amide bioisosteresmonomer2422-2981
0S2;
Assess
HCV NS5B polymerase inhibitors: Tri-substituted acylhydrazines as tertiary amide bioisosteresmonomer2422-2981
0S3;
Assess
CRYSTAL STRUCTURE OF THE RNA DIRECTED RNA POLYMERASE OF HEPATITIS C VIRUSmonomer2420-2975
Assess
Crystal structure of HCV NS5B RNA polymerase with a novel piperazine inhibitormonomer2420-2972
JT1;
Assess
Crystal structure of HCV NS5B RNA polymerase complexed with a tetracyclic inhibitormonomer2420-2963
JTP;
Assess
CRYSTAL STRUCTURE OF HEPATITIS C VIRUS NS5B POLYMERASE FROM 1B GENOTYPE IN COMPLEX WITH A NON-NUCLE…monomer2420-2950
MN;VGI;
Assess
Crystal Structure of Hepatitis C Virus NS5B Polymerase in Complex with Thienopyrrole-Based Finger-L…monomer2420-2950
MN;VGC;
Assess
Crystal structure of Hepatitis C virus polymerase in complex with an allosteric inhibitor (compound…monomer2420-2950
MN;CMF;
Assess
Crystal structure of Hepatitis C virus polymerase in complex with an allosteric inhibitor (compound…monomer2420-2950
MN;POO;
Assess
Structure of MK-3281, a Potent Non-Nucleoside Finger-Loop Inhibitor, in complex with the Hepatitis …monomer2420-2950
IB8;MN;
Assess
TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
3udl.1.Amonomer0.832420-2982
KLI;99.82
Assess